Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CannaHALER PK and Safety in Healthy Volunteers
NCT02729623Phase 1Unknown
- Sponsor
- Kite Pharma
- Start
- Aug 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of cannabis in neuropathic pain (4 arms), sponsored by Kite Pharma. Primary endpoints: Delta-9-tetrahydrocannabinol levels at 30 Minutes, Adverse event monitoring at 4 hours and 1 more. Status: unknown.
02
Drugs
cannabis
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02729623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729623.